Carol C. Pilbeam, MD, PhDProfessor of Medicine and OrthopedicsAssociate Director, MD/PhD Program
|
- Education & Training
- Teaching
- Committees & Organizations
- Research
- Lab Rotations
- Publications
- Presentations
Degree | Institution | Major |
---|---|---|
BS | SMU | Geology |
PhD | Yale University | Geophysics |
MD | Yale University School of Medicine | Medicine |
Post-Graduate Training
Training | Institution | Specialty |
---|---|---|
Internship | Waterbury Hospital | Medicine |
Residency | Waterbury Hospital | Internal Medicine |
Fellowship | Harvard Medical School | Geriatrics |
Awards
Name of Award/Honor | Awarding Organization |
---|---|
Elected Fellow of ASBMR | ASBMR |
Bridging award (national competition, 1 of 2 selected) | American Society of Bone and Mineral Research |
JBMR paper (Chikatzu et al, 2002) selected as 20th Anniversary Classic | JBMR |
Paper chosen as one of 12 best papers published in Journal of Bone and Mineral Research over 20 year period and republished in journal as 20th Anniversary Classic | Journal of Bone and Mineral Research |
Donaghue Foundation Investigator in Health Related Research Award (2002-7) | |
Fred F. Schudy Memorial Research Award | AAOF |
Honorary member, Chinese Hard Tissue Society | |
CT Community Care Award for Research in Geriatrics | |
Travel award XII | International Conference on Calcium Regulating Hormones |
Shannon Award (new investigator award), 1993-1995 | NIH |
Abstract award | American Geriatrics Society |
Brookdale Foundation National Fellowship in Geriatrics 1987-1990 | Brookdale Foundation |
National Science Foundation Fellowship (graduate work at Yale)1964- 1967 | National Science Foundation |
Phi Beta Kappa |
I lead first and second year conferences on bone biology and calcium metabolism and teach skeletal biology in the SBR program for graduate students.
Name & Description | Category | Role | Type | Scope | Start Year | End Year |
---|---|---|---|---|---|---|
Medical School Education Committee 2% | Education Committee | Member | UConn Health | University | 2013 | |
Raisz Gala Fund Clinical and Translational grant competition | Advisory Committee | Grant Reviewer | External | Regional | 2011 | |
Research Misconduct Committee | Research Committee | Member | UConn Health | University | 2011 | |
Medical SAPC—full member | Advisory Committee | Member | UConn Health | University | 2011 | |
Medical SAPC Biology graduate program Executive Committee | Education Committee | Member | UConn Health | University | 2011 | |
University of Michigan Claude Pepper Center, Pilot Grants | Advisory Committee | Grant Reviewer | External | University | 2010 | |
Connecticut Institute for Clinical and Translational Science (CICATS) grants | Advisory Committee | Grant Reviewer | External | State | 2010 | |
T1 Curriculum Development Committee (to develop "Basic Science Methods for the Clinical Investigator" course) | Education Committee | Member | UConn Health | University | 2010 | 2011 |
Academic Advancement Committee (AAC) | Education Committee | Ex Officio Member | UConn Health | University | 2010 | |
Internal reviewer of CTSA application | Advisory Committee | Reviewer | UConn Health | University | 2010 | |
Mentoring Task Force | Education Committee | Member | UConn Health | University | 2010 | |
Organizer, bimonthly meeting of clinical researchers to discuss grant preparation | Advisory Committee | Organizer | UConn Health | University | 2010 | |
NIH Challenge applications | Advisory Committee | Reviewer | External | National | 2009 | |
NIH Skeletal Biology, Development and Disease (SBDD) | Study Section | Study Section Reviewer | External | National | 2009 | |
Organizer, weekly meeting of bone researchers to discuss grant preparation | Advisory Committee | Organizer | UConn Health | University | 2009 | |
Faculty recruitment committees for Center of Aging and New England Musculoskeletal Institute | Education Committee | Member | UConn Health | University | 2009 | 2011 |
UCHC Space Appeals Committee | Advisory Committee | Member | UConn Health | University | 2009 | 2011 |
Physician Scientist Executive Committee | Research Committee | Member | UConn Health | University | 2009 | |
UConn Provost’s Committee on Status of Women | Professional/Scientific Organization | Member | External | University | 2008 | 2010 |
ASBMR Ethics Advisory Committee | Advisory Committee | Member | External | National | 2008 | 2011 |
MD/PhD applicants | Education Committee | Interviewer | UConn Health | University | 2008 | |
Provost’s Commission on the Statue of Women, STEM subcommittee | Research Committee | Member | UConn Health | University | 2008 | 2010 |
Brookdale Foundation Awards in aging | Advisory Committee | Member | External | National | 2007 | |
NIH Skeletal Biology, Structure and Regeneration (SBSR) | Study Section | Study Section Reviewer | External | National | 2007 | |
Ad hoc reviewer of student theses, presentations in Principles of Clinical and Translational Research course | Advisory Committee | Ad Hoc Reviewer | UConn Health | University | 2007 | |
NIH study sections SBDD | Study Section | Ad Hoc Member | External | National | 2006 | 2009 |
NIH study sections SBSR | Study Section | Ad Hoc Member | External | National | 2006 | 2007 |
NIH Roundtable Discussion on Response of Tissue to Mechanical Stimuli | Professional/Scientific Organization | Member | External | National | 2006 | |
ASBMR Bridge Funding Grant competition | Advisory Committee | Advisory Board | External | National | 2006 | |
Canadian Institute of Health Research grants | Advisory Committee | Advisory Board | External | National | 2006 | |
Executive Committee, Center for Interdisciplinary Research in Women’s Health(CIRWH) | Professional/Scientific Organization | Committee Member | UConn Health | University | 2006 | 2007 |
ASBMR’s Women in Bone and Mineral Research committee | Professional/Scientific Organization | Member | External | National | 2005 | 2008 |
International Bone and Mineral Society (IBMS) | Professional/Scientific Organization | Member | External | International | 2005 | |
Faculty of 1000, Rheumatology and Clinical Immunology | Advisory Committee | Reviewer | External | National | 2005 | 2008 |
The Scientific World Journal | Editorial Board | Associate Editor | External | National | 2005 | 2005 |
Founding member, ASBMR committee for women’s professional development(Women in Bone and Mineral Research) | Professional/Scientific Organization | Member | External | National | 2005 | 2007 |
Ad hoc member, UCHC Appeals Committee | Advisory Committee | Ad Hoc Member | UConn Health | University | 2005 | 2007 |
NIH study sections RO3 | Study Section | Ad Hoc Member | External | National | 2004 | |
NIH study sections program project | Study Section | Ad Hoc Member | External | National | 2004 | |
Pilot and exploratory grants for the Musculoskeletal Core Center | Advisory Committee | Grant Reviewer | UConn Health | University | 2004 | 2006 |
ASBMR Women’s Task Force | Professional/Scientific Organization | Member | External | National | 2004 | 2005 |
JURAN best practices working group, committee on grants administration | Advisory Committee | Member | UConn Health | University | 2004 | 2005 |
UCHC GCRC Scientific Advisory Committee | Advisory Committee | Member | UConn Health | University | 2003 | |
NIH study sections,P30 Core Center for Musculoskeletal Disorders | Study Section | Ad Hoc Member | External | National | 2003 | |
Prostaglandins and Other Lipids | Editorial Board | Associate Editor | External | National | 2003 | 2010 |
Clinical grant applications to the General Clinical Research Center (GCRC) | Advisory Committee | Grant Reviewer | UConn Health | University | 2003 | |
Abstract reviewer for annual ASBMR meeting | Advisory Committee | Reviewer | External | National | 2003 | |
Research Services Enhancement Working Group (RSEWG) | Research Committee | Member | UConn Health | University | 2003 | |
Clinical Research Center (GCRC) Senior Advisory Committee | Advisory Committee | Member | UConn Health | University | 2003 | |
Executive Committee for Research, Center for Aging | Research Committee | Member | UConn Health | University | 2003 | |
NIH study sections--Orthopedics | Study Section | Ad Hoc Member | External | National | 2002 | |
Grant applications to UCHC Women’s Health Initiative | Advisory Committee | Ad Hoc Reviewer | UConn Health | University | 2002 | 2007 |
Donaghue Foundation clinical program awards | Advisory Committee | Ad Hoc Reviewer | External | Local | 2002 | 2006 |
Space Advisory Committee (forum for appeals) | Advisory Committee | Member | UConn Health | University | 2002 | 2005 |
Graduate Program Curriculum Committee, representing the Skeletal, Craniofacial and Oral Biology program | Education Committee | Member | UConn Health | University | 2002 | 2004 |
Graduate Program admissions committee | Education Committee | Member | UConn Health | University | 2002 | 2004 |
Advisory Committee for first year graduate students | Advisory Committee | Member | UConn Health | University | 2002 | 2004 |
Member of Research Subcommittee (dealing with distribution of F&A), Dept. of Medicine | Research Committee | Member | UConn Health | University | 2002 | |
Director, Research Development Core, Pepper Center (UCHC Center on Aging) | Research Committee | Director | UConn Health | University | 2000 | 2002 |
Chaired oral session at ASBMR (except for 2005) | Professional/Scientific Organization | Chair | External | National | 1999 | 2007 |
ASBMR Industry Relations Committee | Professional/Scientific Organization | Chair | External | National | 1998 | 2001 |
The Endocrine Society | Professional/Scientific Organization | Member | External | National | 1998 | |
Veteran's Administration grants. | Advisory Committee | Advisory Board | External | National | 1998 | |
Chairperson, ASBMR Industry Relations Committee | Professional/Scientific Organization | Chairperson | External | National | 1998 | 2001 |
Scientific Oversight Committee of the Pepper Center (UCHC Center on Aging) | Research Committee | Member | UConn Health | University | 1998 | 2000 |
Organizer, Endocrine faculty research seminars (“Cookie Club”) | Research Committee | Organizer | UConn Health | University | 1998 | 2001 |
Pilot project and career development applications in aging research, Claude Pepper Center | Advisory Committee | Grant Reviewer | UConn Health | University | 1997 | 2001 |
Organizer, invited speakers for basic research talks in Endocrinology. | Research Committee | Organizer | UConn Health | University | 1996 | 1997 |
Connecticut State Medical Society | Professional/Scientific Organization | Member | External | State | 1994 | 2009 |
Brookdale Foundation Fellowship in aging grants, also 2008 | Advisory Committee | Advisory Board | External | National | 1990 | 2003 |
Brookdale Institute on Aging | Professional/Scientific Organization | Associate | External | National | 1990 | |
Organizer, monthly Research Journal Club for Endocrine Fellows and weekly "Donut Club" for bone metabolism research | Research Committee | Organizer | Other | University | 1989 | 1996 |
American Society for Bone and Mineral Research (ASBMR) | Professional/Scientific Organization | Member | External | National | 1986 | |
American Geriatrics Society | Professional/Scientific Organization | Member | External | National | 1985 | 1995 |
American Medical Association | Professional/Scientific Organization | Member | External | National | 1980 | 1990 |
Sigma Xi | Professional/Scientific Organization | Member | External | National | 1966 | |
ACME | Education Committee | Member | UConn Health | University | ||
MSI Committee | Education Committee | Member | UConn Health | University | ||
Professional Honors Committee | Education Committee | Member | UConn Health | University | ||
T90 Executive Committee | Research Committee | Member | UConn Health | University | ||
F30 Support Committee | Research Committee | Member | UConn Health | University | ||
NIAMS Study Section for Program Project January 2019 | Study Section | Reviewer | External | National | ||
M.D., Ph.D. Program Director | Director, M.D., Ph.D. Program | UConn Health | University | |||
Education Committee | Ex Officio Member | UConn Health | University |
1. Regulation and function of cyclooxygenase-2 (COX-2) in bone. COX-2 is responsible for most prostaglandin regulation in bone. Ongoing research projects include examination of transcriptional regulation of COX-2 in osteoblastic cells and examination of the effects of COX-2 gene disruption on bone resorption and formation. We are particularly interested in the inhibition by COX-2 of the anabolic effects of PTH on bone, an effect that appears to be mediated by cells of the osteoclast lineage.
2. Role of COX-2 in the osteoblastic response to mechanical loading. COX-2 may mediate effects of mechanical loading on bone. We are studying fluid shear stress induction of COX-2 expression--signaling pathways and transactivating factors involved.
Not accepting lab rotation students at this time
Journal Articles
-
Prostaglandin E2 as a therapeutic target in bladder cancer: From basic science to clinical trials.
Prostaglandins & other lipid mediators 2020 Jan;148106409
-
Prostaglandins and Bone.
Handbook of experimental pharmacology 2019 Dec;
-
SATB1 and bladder cancer: Is there a functional link?
Urologic oncology 2018 Oct;3693.e13-93.e21
-
The Role of Pyruvate Dehydrogenase Kinase-4 (PDK4) in Bladder Cancer and Chemoresistance.
Molecular cancer therapeutics 2018 Jun;172004-2012
-
Continuous PTH in Male Mice Causes Bone Loss Because It Induces Serum Amyloid A (SAA).
Endocrinology 2018 May;1592759-2776
-
Optogenetic activation of Plexin-B1 reveals contact repulsion between osteoclasts and osteoblasts.
Nature communications 2017 Jun;815831
-
Spontaneous Glutamatergic Synaptic Activity Regulates Constitutive COX-2 Expression in Neurons: Opposing roles for the transcription factors CREB and Sp1.
The Journal of biological chemistry 2016 Nov;29127279-27288
-
Prostaglandin-mediated inhibition of PTH-stimulated β-catenin signaling in osteoblasts by bone marrow macrophages.
Bone 2016 Feb;85123-130
-
Serum Amyloid A3 Secreted by Preosteoclasts Inhibits Parathyroid Hormone-Stimulated cAMP Signaling in Murine Osteoblasts.
The Journal of biological chemistry 2015 Dec;2913882-94
-
Increased expression of L-selectin (CD62L) in high-grade urothelial carcinoma: A potential marker for metastatic disease.
Urologic oncology 2015 Jan;33(9):387.e17-27
-
Cyclooxygenase-2 suppresses the anabolic response to PTH infusion in mice.
PloS one 2015 Jan;10(3):e0120164
-
Prostaglandin E2 acts via bone marrow macrophages to block PTH-stimulated osteoblast differentiation in vitro.
Bone 2013 Sep;56(1):31-41
-
Macrophage migratory inhibitory factor promotes bladder cancer progression via increasing proliferation and angiogenesis.
Carcinogenesis 2013 Aug;34(12):2891-9
-
Basal bone phenotype and increased anabolic responses to intermittent parathyroid hormone in healthy male COX-2 knockout mice.
Bone 2010 Aug;47(2):341-52
-
Parathyroid hormone induction of cyclooxygenase-2 in murine osteoblasts: role of the calcium-calcineurin-NFAT pathway.
Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research 2010 Apr;25(4):819-29
-
Role of the cyclooxygenase pathway in chemotherapy-induced oral mucositis: a pilot study.
Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer 2010 Jan;18(1):95-103
-
Neuropeptide Y is expressed by osteocytes and can inhibit osteoblastic activity.
Journal of cellular biochemistry 2009 Oct;108(3):621-30
-
Effects of global or targeted deletion of the EP4 receptor on the response of osteoblasts to prostaglandin in vitro and on bone histomorphometry in aged mice.
Bone 2009 Jul;45(1):98-103
-
Effects of prostaglandin E2 on bone in mice in vivo.
Prostaglandins & other lipid mediators 2009 Jun;89(1-2):20-5
-
Bone morphogenetic protein 2 enhances PGE<sub>2</sub>-stimulated osteoclast formation in murine bone marrow cultures
Prostaglandins and Other Lipid Mediators 2009 Jan;90(40241):76-80
-
Effects of Prostaglandin E2 on bone in mice in vivo.
Prostaglandins Other Lipid Mediat 2009 Jan;8920-25
-
Regulation of the prostaglandin pathway during development of invasive bladder cancer in mice.
Prostaglandins & other lipid mediators 2009 Jan;88(1-2):36-41
-
Anabolic effects of PTH in cyclooxygenase-2 knockout osteoblasts in vitro.
Biochemical and biophysical research communications 2008 Aug;372(4):536-41
-
Effect of deletion of the prostaglandin EP2 receptor on the anabolic response to prostaglandin E2 and a selective EP2 receptor agonist.
Prostaglandins & other lipid mediators 2008 Jun;86(1-4):35-40
-
Effect of MKP-1 deletion on the fluid shear stress induction of COX-2 expression in osteoblasts.
J Bone Miner Res 2008 Jan;23S234
-
Measurement of muscle disease by quantitative second-harmonic generation imaging.
Journal of biomedical optics 2008 Jan;13(4):044018
-
Cyclooxygenase-2 gene disruption promotes proliferation of murine calvarial osteoblasts in vitro.
Bone 2007 Jul;41(1):68-76
-
Strontium ranelate promotes osteoblastic differentiation and mineralization of murine bone marrow stromal cells: involvement of prostaglandins.
Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research 2007 Jul;22(7):1002-10
-
Effects of prostaglandin E2 and lipopolysaccharide on osteoclastogenesis in RAW 264.7 cells.
Prostaglandins, leukotrienes, and essential fatty acids 2007 Jan;77(3-4):181-6
-
Null mutation in macrophage migration inhibitory factor prevents muscle cell loss and fibrosis in partial bladder outlet obstruction.
American journal of physiology. Renal physiology 2006 Dec;291(6):F1343-53
-
Fluid flow induces Rankl expression in primary murine calvarial osteoblasts.
Journal of cellular biochemistry 2006 Aug;98(5):1271-83
-
Overexpression of COX-2 in human osteosarcoma cells decreases proliferation and increases apoptosis.
Cancer research 2006 Jul;66(13):6657-64
-
Role of Cbfa1/Runx2 in the fluid shear stress induction of COX-2 in osteoblasts.
Biochemical and biophysical research communications 2006 Mar;341(4):1225-30
-
Effect of deletion of the prostaglandin EP4 receptor on stimulation of calcium release from cultured mouse calvariae: impaired responsiveness in heterozygotes.
Prostaglandins & other lipid mediators 2005 Dec;78(1-4):19-26
-
Do cyclooxygenase-2 knockout mice have primary hyperparathyroidism?
Endocrinology 2005 Apr;146(4):1843-53
-
Biphasic effect of prostaglandin E2 on osteoclast formation in spleen cell cultures: role of the EP2 receptor.
Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research 2005 Jan;20(1):23-9
-
Differential regulation of platelet-derived growth factor stimulated migration and proliferation in osteoblastic cells.
Journal of cellular biochemistry 2004 Nov;93(4):741-52
-
Levels and trends of radioactive contaminants in the Greenland environment.
The Science of the total environment 2004 Sep;331(1-3):53-67
-
Extracellular calcium induces COX-2 in osteoblasts via a PKA pathway.
Biochemical and biophysical research communications 2004 Sep;322(2):395-402
-
Role of cyclooxygenase-2 in bone resorption.
Journal of UOEH 2003 Jun;25(2):185-95
-
Bone morphogenetic protein 2 induces cyclo-oxygenase 2 in osteoblasts via a Cbfal binding site: role in effects of bone morphogenetic protein 2 in vitro and in vivo.
Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research 2002 Aug;17(8):1430-40
-
Cell-to-Cell adhesion via intercellular adhesion molecule-1 and leukocyte function-associated antigen-1 pathway is involved in 1alpha,25(OH)2D3, PTH and IL-1alpha-induced osteoclast differentiation and bone resorption.
Endocrine journal 2002 Aug;49(4):483-95
-
Effects of prostaglandin E2 on gene expression in primary osteoblastic cells from prostaglandin receptor knockout mice.
Bone 2002 Apr;30(4):567-73
-
Prostaglandin receptor EP2 mediates PGE2 stimulated hypercalcemia in mice in vivo.
Prostaglandins & other lipid mediators 2002 Apr;67(3-4):173-80
-
Regulation of fibroblast growth factor 2 and fibroblast growth factor receptors by transforming growth factor beta in human osteoblastic MG-63 cells.
Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research 2002 Mar;17(3):502-12
-
Fluid flow induction of cyclo-oxygenase 2 gene expression in osteoblasts is dependent on an extracellular signal-regulated kinase signaling pathway.
Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research 2002 Feb;17(2):266-74
-
Effects of selective prostaglandin EP4 receptor antagonist on osteoclast formation and bone resorption in vitro.
Bone 2002 Jan;30(1):159-63
-
Fluid flow induction of cyclooxygenase-2 gene expression in osteoblasts depends on the ERK signaling pathway.
J Bone Miner Res 2002 Jan;17266-274
-
Involvement of CCAAT enhancer binding protein transcription factors in the regulation of prostaglandin G/H synthase 2 expression by interleukin-1 in osteoblastic MC3T3-E1 cells.
Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research 2000 Jun;15(6):1138-46
-
Identification of multiple cis-acting elements mediating the induction of prostaglandin G/H synthase-2 by phorbol ester in murine osteoblastic cells.
Journal of cellular biochemistry 2000 May;78(2):197-209
-
Prostaglandin G/H synthase-2 is required for maximal formation of osteoclast-like cells in culture.
The Journal of clinical investigation 2000 Mar;105(6):823-32
-
Prostaglandin G/H synthase-2 is required for maximal stimulation of osteoclast-like cell formation in murine marrow and spleen cultures.
J Clin Invest 2000 Jan;105823-832
-
Low dose estrogen and calcium have an additive effect on bone resorption in older women.
The Journal of clinical endocrinology and metabolism 1999 Jan;84(1):179-83
-
Regulation of prostaglandin G/H synthase-2 expression by interleukin-1 in human osteoblast-like cells.
Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research 1998 Jul;13(7):1066-75
-
Mice lacking the type I interleukin-1 receptor do not lose bone mass after ovariectomy.
Endocrinology 1998 Jun;139(6):3022-5
-
Molecular cloning and expression of a rat prostaglandin E2 receptor of the EP2 subtype.
Prostaglandins 1997 Oct;54(4):713-25
-
Parathyroid hormone increases prostaglandin G/H synthase-2 transcription by a cyclic adenosine 3',5'-monophosphate-mediated pathway in murine osteoblastic MC3T3-E1 cells.
Endocrinology 1997 Sep;138(9):3594-600
-
Differential effects of nonsteroidal anti-inflammatory drugs on constitutive and inducible prostaglandin G/H synthase in cultured bone cells.
Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research 1997 Aug;12(8):1198-203
-
Transcriptional induction of cyclooxygenase-2 in osteoblasts is involved in interleukin-6-induced osteoclast formation.
Endocrinology 1997 Jun;138(6):2372-9
-
Pulsating fluid flow stimulates prostaglandin release and inducible prostaglandin G/H synthase mRNA expression in primary mouse bone cells.
Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research 1997 Jan;12(1):45-51
-
Regulation of inducible prostaglandin G/H synthase by interleukin-1, transforming growth factors-alpha and -beta, and prostaglandins in bone cells.
Advances in experimental medicine and biology 1997 Jan;400B(B):617-23
-
Lack of evidence for an increase in interleukin-6 expression in adult murine bone, bone marrow, and marrow stromal cell cultures after ovariectomy.
Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research 1996 Dec;11(12):1926-34
-
Parathyroid hormone induces prostaglandin G/H synthase-2 expression by a cyclic adenosine 3',5'-monophosphate-mediated pathway in the murine osteoblastic cell line MC3T3-E1.
Endocrinology 1996 Dec;137(12):5435-40
-
Interleukin-4 inhibits prostaglandin G/H synthase-2 and cytosolic phospholipase A2 induction in neonatal mouse parietal bone cultures.
Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research 1996 Mar;11(3):358-66
-
Intact insulin-like growth factor binding protein-5 (IGFBP-5) associates with bone matrix and the soluble fragments of IGFBP-5 accumulated in culture medium of neonatal mouse calvariae by parathyroid hormone and prostaglandin E2-treatment.
Journal of cellular physiology 1996 Feb;166(2):370-9
-
The effect of a short course of calcium and vitamin D on bone turnover in older women.
Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA 1996 Jan;6(4):314-9
-
The short term effects of tamoxifen on bone turnover in older women.
The Journal of clinical endocrinology and metabolism 1995 Nov;80(11):3287-91
-
Transcriptional induction of prostaglandin G/H synthase-2 by basic fibroblast growth factor.
The Journal of clinical investigation 1995 Aug;96(2):923-30
-
Ovariectomy enhances and estrogen replacement inhibits the activity of bone marrow factors that stimulate prostaglandin production in cultured mouse calvariae.
The Journal of clinical investigation 1995 Jul;96(1):539-48
-
Autoregulation of inducible prostaglandin G/H synthase in osteoblastic cells by prostaglandins.
Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research 1995 Mar;10(3):406-14
-
Expression and regulation of prostaglandin F receptor mRNA in rodent osteoblastic cells.
Prostaglandins 1995 Jan;50(5-6):349-58
-
Fracture incidence in postmenopausal women with primary hyperparathyroidism. ,
Surgery 1995 Jan;118109-114
-
Anabolic effects of 3,3',5-triiodothyronine and triiodothyroacetic acid in cultured neonatal mouse parietal bones.
Endocrinology 1994 Sep;135(3):971-6
-
Regulation of the two prostaglandin G/H synthases by parathyroid hormone, interleukin-1, cortisol, and prostaglandin E2 in cultured neonatal mouse calvariae.
Endocrinology 1994 Sep;135(3):1157-64
-
Measurement of interleukin-1 stimulated constitutive prostaglandin G/H synthase (cyclooxygenase) mRNA levels in osteoblastic MC3T3-E1 cells using competitive reverse transcriptase polymerase chain reaction.
Endocrine research 1994 Aug;20(3):219-33
-
The short-term effects of conjugated estrogen on bone turnover in older women.
The Journal of clinical endocrinology and metabolism 1994 Aug;79(2):366-71
-
Stimulation of prostaglandin E2 production by interleukin-1 alpha and transforming growth factor alpha in osteoblastic MC3T3-E1 cells.
Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research 1994 Jun;9(6):817-23
-
Comparison of the effects of 3,5,3'-triiodothyroacetic acid and triiodothyronine on bone resorption in cultured fetal rat long bones and neonatal mouse calvariae.
Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research 1994 Feb;9(2):247-53
-
The anabolic effects of progesterone on fetal rat calvaria in tissue culture.
Journal of the Society for Gynecologic Investigation 1994 Jan;1(4):302-9
-
Differential regulation of inducible and constitutive prostaglandin endoperoxide synthase in osteoblastic MC3T3-E1 cells.
The Journal of biological chemistry 1993 Dec;268(34):25643-9
-
Comparison of the effects of various lengths of synthetic human parathyroid hormone-related peptide (hPTHrP) of malignancy on bone resorption and formation in organ culture.
Bone 1993 Jan;14(5):717-20
-
Differential regulation of the two genes for prostaglandin endoperoxide synthase in MC3T3 E1 osteoblastic cells.
J Biol Chem 1993 Jan;26825643-25649
-
Production of both 92 and 72 kDa gelatinases by bone cells.
Matrix 1992 Jan;12282-290
-
Effect of 1,25-dihydroxyvitamin D3 on prostaglandin E2 production in cultured mouse parietal bones.
Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research 1991 Dec;6(12):1339-44
-
Mechanism of regulation of prostaglandin production by parathyroid hormone, interleukin-1, and cortisol in cultured mouse parietal bones.
Endocrinology 1991 May;128(5):2503-10
-
Effects and regulation of prostaglandins in bone: Possible implications for the pathogenesis of osteoporosis
Journal of Bone and Mineral Metabolism 1991 Jan;9(2):39-44
-
Effects of androgens on parathyroid hormone and interleukin-1-stimulated prostaglandin production in cultured neonatal mouse calvariae.
Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research 1990 Nov;5(11):1183-8
-
A long term study to evaluate the relative contributions of exposure to sunlight and diet on the circulating concentrations of 25 OH D in an elderly population in Boston.
Amer J Clin Nutrition 1990 Jan;511075 -1081
-
Inhibition by 17 beta-estradiol of PTH stimulated resorption and prostaglandin production in cultured neonatal mouse calvariae.
Biochemical and biophysical research communications 1989 Sep;163(3):1319-24
-
Deep earthquake initiation by phase transformations.
J Geophys Res 1976 Jan;81985-988
-
Stress on the bottom of an estuary.
Nature 1975 Jan;257575-577
-
Acoustic velocities and energy losses in granular aggregates.
J Geophys Res 1973 Jan;78810-824
-
Contact thermal conductivity in lunar aggregates.
J Geophys Res 1973 Jan;785233 -5236
Book Chapters
-
Prostaglandins and Bone Metabolism
Principles of Bone Biology 2019 Aug;(August 2019):
-
Current Therapy in Orthodontics
Mechanotransduction of Orthodontic Forces 2009 Jan;341-352
-
Principles of Bone Biology
Prostaglandins and Bone Metabolism 2008 Jan;1235-1271
-
The Eicosanoids
Prostaglandins, Leukotrienes, and Bone Metabolism 2004 Jan;
-
Principles of Bone Biology, second edition
Prostaglandins and Leukotrienes 2002 Jan;874-994
-
Therapeutic Roles of Selective COX-2 Inhibitors
Cyclooxygenase-2 and bone turnover 2001 Jan;307-328
-
Oxford Textbook of Geriatric Medicine
Osteomalacia 2000 Jan;
-
Clinical Significance and Potential of Selective COX-2 Inhibitors
Cyclooxgenase-2 and bone resorption. 1998 Jan;49-56
-
Principles of Bone Biology
Prostaglandins and Leukotrienes. 1996 Jan;715-728
-
Oxford Textbook of Geriatric Medicine
Osteomalacia. 1992 Jan;
-
Osteoporosis 1990
Prostaglandins and bone metabolism: Possible role in osteoporosis. 1990 Jan;253-258
-
Geriatric Medicine
Osteoporosis. 1988 Jan;431-439
Abstracts
-
Effects of MKP-1 deletion on osteoblast growth and differentiation.
Available at http://www.asbmr.org/Meetings/AnnualMeeting/AbstractDetail.aspx?aid=b9f49eaa-e06d-423b-9ec4-629d067dc93e.
J Bone Miner Res 2009 Jan;24((Suppl 1)):
-
Targeted overexpression of Cox-2 in osteoblasts.
J Bone Miner Res 2009 Jan;24 ((Suppl 1)):
-
Mechanism of BMP-2 enhancement of PGE2 stimulated osteoclastogenesis.
J Bone Miner Res 2008 Jan;23S263
-
Nutritional considerations in institutionalized elders.
Current opinion in clinical nutrition and metabolic care 2008 Jan;11(1):1-6
-
PTH induces COX-2 in MC3T3-E1 osteoblasts via cAMP-PKA and caclcium-calcineurin pathways.
J Bone Miner Res 2008 Jan;23S140
-
BMP-2 induces sustained expression of COX-2 in MC3T3-E1 osteoblasts.
J Bone Miner Res 2007 Jan;22S165
-
Demonstration of an anabolic effect of prostaglandin E 2 on bone in CD-1 mice.
J Bone Miner Res 2007 Jan;22S167
-
Role of prostaglandins in strontium ranelate effects on osteoblastic differentiation and growth factor production.
J Bone Miner Res 2007 Jan;22S445
-
Regulation of MAPK phosphatase-1 by fluid flow in MC3T3-E1 osteoblastic cells.
J Bone Miner Res 2006 Jan;21(S1)S372
-
Macrophage migration inhibitory factor mediates smooth muscle death in bladder outlet obstruction.
J Urol 2005 Jan;17338
-
Fluid flow regulation of the 3’- untranslated region of cyclooxygnase-2 in MC3T3-E1 cells.
J Bone Miner Res 2005 Jan;20(S1)S169
-
Null mutation in macrophage migration inhibitory factor (MIF) inhibits compensatory smooth muscle growth in bladder outlet obstruction.
J Am Geriatr Soc. 2005 Jan;538
-
Fluid shear stress induces MMP-13 in murine osteoblastic cells.
J Miner Res 2004 Jan;19(S1)S137
-
Effect of exogenous and endogenous prostaglandin E2 on osteoclastogenesis in the RAW 264.7 macrophage cell line.
J Bone Miner Res 2004 Jan;19(S1)S409
-
Effects of global or targeted deletion of the EP4 receptor on the response of cultured osteoblasts to prostaglandin E2.
J Bone Miner Res 2004 Jan;19(S1)S5
-
Endogenous COX-2 gene expression does not alter apoptosis in murine osteoblastic cells.
J Bone Miner Res 2004 Jan;19(S1)S140
-
Five minutes of fluid shear stress is sufficient to induce cyclooxygenase-2 in MC3T3-E1 cells.
J Miner Res 2004 Jan;19(S1)(S137):
-
Fluid shear stress induces cyclooxygenase-2 via activation of protein kinase D in murine primary osteoblasts.
J Miner Res 2004 Jan;19(S1)S390
-
Fluid shear stress induces RANKL expression in primary osteoblastic cells.
J Miner Res 2004 Jan;19(S1)S391
-
Overexpression of COX-2 in Saos- 2 human osteosarcoma cells increases apoptosis via oxidative stress.
J Bone Miner Res 2004 Jan;19(S1)S140
-
Parathyroid hormone injection induces cyclooxygenase-2 in bone, kidney, and muscle in vivo.
J Miner Res 2004 Jan;19(S1)S335
-
Transcription factors involved in the regulation of IL-6 in mouse calvarial osteoblasts by vasoactive intestinal peptide.
J Bone Miner Res 2004 Jan;19(S1)S265
-
Early induction of cyclooxygenase-2 in osteoblasts by fluid flow depends on the protein kinase C signaling pathway.
J Bone Miner Res 2003 Jan; 18(S2)S218
-
Overexpression of cyclooxygenase-2 decreases proliferation of osteoblastic cells.
J Bone Miner Res 2003 Jan;18(S2)S340
-
Platelet-derived growth factor stimulates osteoblastic migration and proliferation via independent signaling pathways.
J Bone Miner Res 2003 Jan;18(S2)S194
-
Prostaglandin E2 stimulation of osteoclast formation in hematopoietic cell cultures is mediated by a soluble T cell factor.
J Bone Miner Res 2003 Jan;18(S2)S236
-
Biphasis effect of prostaglandin E2 on osteoclast formation from spleen cells.
J Bone Miner Res 2002 Jan;17(S1)S345
-
Effects of Prostaglandin E2 (PGE2) and selective prostaglandin E receptor (EP) agonists on 3’5’ cyclic adenosine monophosphate (cAMP) production in osteoblastic cells from wild type and EP2 or EP4 knockout mice.
J Bone Miner Res 2002 Jan;17(S1)S441
-
Nutraceutical fatty acids as biochemical and molecular modulators of skeletal biology.
Journal of the American College of Nutrition 2001 Oct;20(5 Suppl):410S-416S; discussion 417S-420S
-
Signaling pathways for the fluid shear stress induction of cyclooxygenase-2 in murine osteoblasts.
J Bone Miner Res 2001 Jan;16(S1)S255
-
Effects of aging on the regulation of osteoclast formation in murine bone marrow cultures.
J Bone Miner Res 2000 Jan;15(S1)S237
-
IL-1 regulation of osteoblastic differentiation in murine bone marrow and primary osteoblastic cultures.
J Bone Miner Res 2000 Jan;15(S1)S508
-
Involvement of AP-1 and CRE sites in the parathyroid hormone induction of COX-2 promoter activity in osteoblastic MC3T3-E1 cells.
J Bone Miner Res 2000 Jan;15(S1)S497
-
Effects of prostaglandin G/H synthase-2 knockout on bone.
J Bone Miner Res 1999 Jan;14(S1)S172
-
Osteoblasts from interleukin 1 receptor type 1 knockout mice have a markedly reduced capacity to support osteoclast function.
J Bone Miner Res 1999 Jan;14(S1)S164
-
Prostaglandins induce ICER expression in osteoblastic cells and mouse calvariae.
J Bone Miner Res 1999 Jan;14(S1)S350
-
Transcriptional regulation of prostaglandin G/H synthase-2 in transgenic mice.
J Bone Miner Res 1999 Jan;14(S1)(S472):
-
AP-1 and CRE sites jointly mediate the induction of prostaglandin G/H synthase-2 promoter activity basic fibroblast growth factor in osteoblastic MC3T3-E1 cells.
J Bone Miner Res 1998 Jan;13(S1)S245
-
Decreased osteoclastogenic responses in marrow cultures from mice with disruption of the PGHS-2 gene.
J Bone Miner Res 1998 Jan;13(S1)S330
-
Expression and regulation of fibroblast growth factor-2 by cytokines and growth factors in human osteoblasts.
J Bone Miner Res 1998 Jan;13(S1)S440
-
Identification of promoter sites mediating induction of transcription of PGHS-2 by phobol ester in MC3T3-E1 cells.
Bone 1998 Jan;2216S
-
Turnor necrosis factor-? stimulation of prostaglandin G/H synthase-2 promoter activity in osteoblastic MC3T3-E1 cells requires and intact AP-1 site.
J Bone Miner Res 1998 Jan;13(S1)S354
-
Basic fibroblast growth factor stimulates bone resorption through mitogenic effects on immature osteoblastic cells as well as cyclooxygenase-2 induction.
J Bone Min Res 1997 Jan;12(S1)S209
-
Downregulation of mRNA expression for the "decoy" interleukin-1 receptor 2 by ovariectomy in mice.
J Bone Min Res 1997 Jan;12(S1)S433
-
Expression and regulation of prostaglandin F receptor mRNA in rodent osteoblastic cells.
J Bone Min Res 1997 Jan;12 (S1)S189
-
Induction of the prostaglandin G/H synthase-2 gene by Interleukin-1 in MC3T3-E1 cells is mediated by C/EBP transcription factors.
J Bone Min Res 1997 Jan;12(S1)S433
-
Overexpression and suppression of prostaglandin EP2 and FP receptors in rat osteoblastic cells.
J Bone Min Res 1997 Jan;12(S1)190
-
The expression and regulation of IL-1? mRNA in human osteosarcoma MG-63 cells.
J Bone Min Res 1997 Jan;12(S1)S433
-
Estrogen and calcium have an additive effect on bone turnover in older women.
J Bone Min Res 1996 Jan;1(S1)(S450):
-
Molecular cloning and expression of a rat prostaglandin E2 receptor of the EP2 subtype.
J Bone Min Res 1996 Jan;11(S1)S174
-
The effect of estrogen on serum cross-linked N-telopeptides of type I collagen.
J Bone Min Res 1996 Jan;11(S1)S449
-
Transcriptional induction of prostaglandin G/H synthase-2 by transforming growth factor-beta1 in osteoblastic MC3T3-E1 cells requires an intact C/EBP (N-IL6) site.
J Bone Min Res 1996 Jan;11(S1)S378
-
Identification of prostaglandin receptor mRNA in bone cells by reverse transcriptase polymerase chain reaction methodology.
J Bone Min Res 1995 Jan;10(S1)S420
-
Increased production of inflammatory mediators immed-iately after surgery by marrow stromal cell cultures from sham operated and ovariectomized mice.
J Bone Min Res 1995 Jan;10(S1)S346
-
Low dose conjugated estrogen reduces biochemical markers of bone turnover in older women.
J Bone Min Res 1995 Jan;10(S1)S256
-
Parathyroid hormone induces prostaglandin synthase-2 gene expression in MC3T3-E1 cells.
J Bone Min Res 1995 Jan;10(S1)S280
-
Retinoic acid inhibits induction of prostaglandin G/H synthase-2 mRNA and promoter activity in MC3T3 E 1 osteoblastic cells.
J Bone Min Res 1995 Jan;10(S1)S496
-
Transcriptional regulation prostaglandin G/H synthase 2 by transforming growth factor ß in MC3T3 E1 cells.
Bone 1995 Jan;16(S1)39
-
Autoregulation of inducible prostaglandin G/H synthase in osteoblastic cells by prostaglandins.
Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research 1994 Jan;10(3):406-14
-
Nuclear factor binding to an NF-IL-6 site in the prostaglandin G/H synthase 2 promoter induced by IL 1 in MC3T3 E1 cells.
J Bone Min Res 1994 Jan;9(S1)S122
-
Ovariectomy or estrogen treatment do not alter interleukin 6 mRNA expression in adult murine bone and bone marrow.
J Bone Min Res 1994 Jan;9(S1)S389
-
Regulation of inducible prostaglandin G/H synthase mRNA levels and promoter activity by basic fibroblast growth factor in osteoblastic cells.
J Bone Min Res 1994 Jan;9(S1)S124
-
Regulation of prostaglandin production and bone resorption by interleukin 4 (IL 4) in cultured mouse calvariae.
J Bone Min Res 1994 Jan;9(S1)S236
-
The effect of calcium and vitamin D supplementation on bone turnover in healthy older women.
J Bone Min Res 1994 Jan;9(S1)S391
-
Auto amplification of inducible prostaglandin G/H synthase (cyclooxygenase)in osteoblastic MC3T3 E1 and Pyla cells.
J Bone Miner Res 1993 Jan;8(S1)S161
-
Effects of a short course of conjugated estrogen on bone turnover in older women
J Bone Miner Res 1993 Jan; 8(S1):S253
-
Insulin like growth factor binding protein 5 accumulates in bone matrix and is released by parathyroid hormone and prostaglandin E2.
J Bone Miner Res 1993 Jan;8(S1)S237
-
Quantitation of constitutive prostaglandin G/H synthase (cyclooxygenase) mRNA levels in mouse osteo-blastic MC3T3 E1 cells using competitive polymerase chain reaction.
J Bone and Miner Res 1993 Jan;8(S1)(S299):
-
Regulation of inducible prostaglandin G/H synthase (cyclooxygenase) by interleukin 1 and transform¬ing growth factors ? and ß in osteoblastic cells.
J Bone Miner Res 1993 Jan;8(S1)S299
-
Role of inducible prostaglandin G/H synthase (cyclooxygenase) in the regulation of prostaglandin produc¬tion in cultured mouse calvariae.
J Bone Miner Res 1993 Jan;8(S1)S159
-
Separate regulation of the mRNA transcripts for the two prostaglandin endoperoxide synthases in MC3T3 E1 osteoblastic cells by serum and glucocorticoid.
Calcif Tissue Int 1993 Jan;52(S1)S99
-
Short term effects of tamoxifen on bone turnover in older postmenopausal women.
J Bone Miner Res 1993 Jan; 8(S):S252
-
Comparison of the effects of 3,5,3' triiodothyro¬acetic acid and triiodothyronine on bone resorption in cultured fetal rat long bones.
J Bone Miner Res 1992 Jan;7(S1)S145
-
Short term effects of estrogen on bone turnover in older women.
Bone and Mineral 1992 Jan;17(S1)357
-
Estradiol inhibition of 1,25 dihydroxyvitamin D3 stimulated release in cultured fetal rat long bones.
J Bone Miner Res 1991 Jan;6(S1)S99
-
Inhibition of prostaglandin E2 production by 17ß estradiol in osteoblast like cells.
Calcif Tissue Int 1991 Jan;48(S1)A31
-
Comparison of the effects of various forms of synthetic human parathyroid hormone related peptide of malignancy on bone resorption and formation in organ culture.
J Bone Miner Res 1990 Jan;5(S2)S475
-
In vitro inhibition of interleukin 1 stimulated prostaglandin E2 production by 17ß estradiol.
Calcif Tissue Int 1990 Jan;46(S2)A44
-
Stimulation of prostaglandin E2 production in an immortalized osteoblastic cell line (Py1a) by arachidonic acid, transforming growth factor 6, and interleukin 1.
J Bone Miner Res 1990 Jan;5(S2)S310
-
Effects of testosterone on IL 1 and PTH stimulated prostaglandin production and resorption in neonatal mouse calvariae.
J Bone Miner Res 1989 Jan;4(S1):S283
-
In vitro inhibition of PTH stimulated prostaglandin (PGE2) production by 17 beta estradiol (ßE2).
J Bone Miner Res 1988 Jan;3(S1)S219
Conference Papers
-
BMP-2 enhances PGE2-stimulated osteoclastogeneis.
2006 Jan;
-
Cyclooxygenase-2 knockout does not prevent bone loss after ovariectomy.
J Bone Miner Res 2006 Jan;21(S1)S413
-
Mice with a null mutation for macrophage migration inhibitory factor have lower stage tumors in a model of bladder cancer.
Taylor won New Investigator Award.
2006 Jan;
-
Locomotion in vitamin D receptor gene knockout mice.
2005 Jan;
-
Macrophage migration inhibitory factor (MIF) inhibits compensatory smooth muscle growth in bladder outlet obstruction.
2005 Jan;
-
Stimulation of cAMP production and cyclooxygenase-2 by prostaglandin E(2) and selective prostaglandin receptor agonists in murine osteoblastic cells.
Bone 2004 May;34(5):827-34
-
The effect of deletion of cyclooxygenase-2, prostaglandin receptor EP2, or EP4 in bone marrow cells on osteoclasts induced by mouse mammary cancer cell lines.
Bone 2003 Nov;33(5):798-804
-
Extracellular calcium is a potent inducer of cyclo-oxygenase-2 in murine osteoblasts through an ERK signaling pathway.
Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research 2003 Oct;18(10):1813-24
-
Fluid flow induces COX-2 expression in MC3T3-E1 osteoblasts via a PKA signaling pathway.
Biochemical and biophysical research communications 2002 Sep;297(1):46-51
-
Transforming growth factor-beta1 regulation of prostaglandin G/H synthase-2 expression in osteoblastic MC3T3-E1 cells.
Endocrinology 1997 Nov;138(11):4672-82
-
The role of prostaglandins in the regulation of bone metabolism.
Clinical orthopaedics and related research 1995 Apr;(313):36-46
-
Prostaglandins: mechanisms of action and regulation of production in bone.
Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA 1993 Jan;3 Suppl 1(SUPPL. 1):136-40
Editorials
-
Hip fractures and vitamin D. Guest editorial
Complications in Orthopedics 1991 Jan;
Erratums
Notes
-
Commentary: Take two aspirin for osteoporosis? Does aspirin have potential as an anti-osteoporosis drug? A new study by Yamaza and colleagues, published in PLoS One suggests that it just might.
IBMS BoneKEy Newsletter 2008 Jan;Dec. 15
Reviews
-
Prostaglandins in bone: bad cop, good cop?
Trends in endocrinology and metabolism: TEM 2010 May;21(5):294-301
-
Role of the prostaglandin pathway and the use of NSAIDs in genitourinary malignancies.
Expert review of anticancer therapy 2008 Jul;8(7):1125-34
-
Treatment of osteoporosis.
Annual review of medicine 1995 Jan;46249-56
-
Effects and regulation of prostaglandins in bone: Possible implications for the pathogenesis of osteoporosis. ,.
J Bone Miner Metab (Japan), 1992 Jan;9(39 ):44
-
Mechanical properties of granular media.
Annual Review of Earth 1975 Jan;3343-360
Title or Abstract | Type | Sponsor/Event | Date/Year | Location |
---|---|---|---|---|
Anabolic effects of intermittent PTH are impaired in MAP kinase phosphatase-1 knockout mice. Xu M, Ma L, Choudhary S, Vosnesensky O, Adams G, Raisz L, Pilbeam C. | Talk | American Society of Bone and Mineral Research | 2010 | Toronto, Canada |
Intermittent PTH has increased anabolic effects in cyclooxygenase-2 knockout mice. Xu won travel award. Xu M, Gao Q, Voznesensky O, Choudhary S, Diaz-Doran V, Raisz L, and Pilbeam C. | Talk | American Society of Bone and Mineral Research | 2007 | Honolulu, Hawaii |
COX-2 and PTH | Talk | Musculoskeletal Institute Research Day | 2006 | |
Discussant; presentation of my research | Talk | Orthopedics Resident’s Graduation | 2006 | |
Effects of global or targeted deletion of the EP4 receptor on the response of cultured osteoblasts to prostaglandin E2. Raisz LG, Alander CA, Zhan P, Breyer MD, Kream BE, and Pibeam CC. | Talk | American Society of Bone and Mineral Research | 2004 | |
COX-2 and osteosarcoma | Talk | Research Retreats or Research Days: UCONN Comprehensive Cancer Center Retreat | 2004 | UCONN |
update on research | Talk | Center on Aging Retreat | 2004 | |
BMP-2 induces COX-2 in osteoblasts via a Cbfa1 binding site: Role in osteoblast and osteoclast differentiation and ectopic bone formation. | Talk | Bones and Teeth Gordon Conference | 2001 | Kimball Academy, NH. |
Prostaglandins and Bone. | Talk | Geriatrics Division, University of Wisconsin | 2000 | Madison, WI |
topics included mechanical loading of bone, role of COX-2 in bone | Talk | Geriatrics grand rounds | 2000 | UCHC |
Function of COX-2 in bone. The Potential of Specific Cox-2 Inhibition | Talk | William Harvey Research Conference | 1999 | Lisbon, Portugal |
Role of COX-2 in bone turnover. | Talk | Merck management meeting | 1999 | Skamandia Lodge, Steveson, WA |
Bone metabolism in prostaglandin G/H synthase deficient mice. | Talk | Bones and Teeth Gordon Conference | 1999 | Kimball Academy, NH |
Osteoclast function is inhibited in marrow cultures from COX-2 knockout mice. Okada Y, Freeman A, Tomita M, Morham S, and Pilbeam C. | Talk | Eicosanoids and Other Bioactive Lipids in Cancer, Inflammation and Related Diseases | 1999 | Boston, MA |
Endotoxin induction of luciferase activity in mice transgenic for a COX-2 promoter-luciferase reporter construct. Freeman A, Herschman H, Voznesensky O, Bhatt A, Clark S, Pilbeam C. | Talk | Eicosanoids and Other Bioactive Lipids in Cancer, Inflammation and Related Diseases | 1999 | Boston, MA |
Effects of prostaglandin G/H synthase-2 knockout on bone. Okada won Young Investigator Award for his presentation. Okada Y, Tomita M, Tsurukami H, Nakamura T, Alander C, Sohn J, Raisz L, Lorenzo J, Pilbeam C. | Talk | Annual Meeting of the American Society for Bone and Mineral Research | 1999 | St. Louis, MO |
The role of IL-1 in the bone loss of estrogen withdrawal. | Talk | Gerontological Society of America workshop | 1998 | Philadelphia, PA. |
COX-2 and bone resorption. | Talk | Clinical Roundtable: Preferential Cyclooxygenase Inhibitors-Their Impact in the Prevention and Manag | 1998 | Frankfurt, Germany. |
Role of COX-2 in the inflammatory process of bone resorption. Clinical Benefits of Selective COX-2 Inhibitors | Talk | William Harvey Research Conference | 1998 | Boston,MA |
Role of COX-2 in bone formation and resorption. | Talk | Workshop: Is COX-2 a Physiologic Necessity? | 1998 | NYC |
COX-2 and bone resorption. The Promise of Specific Cox-2 Inhibition by Novel Agents | Talk | William Harvey Research Conference | 1998 | Cannes, France |
Regulation of inducible prostaglandin G/H synthase in bone. | Talk | International Conference on Biological Mechanisms of Tooth Eruption, Resorption, and Replacement by | 1997 | Toledo, Spain |
Expression and regulation of Cox-2 in bone. | Talk | First International Workshop on Cox-2 | 1997 | New Orleans |
Retinoic acid transcriptionally inhibits prostaglandin G/H synthase expression in osteoblastic cells. Pilbeam C, Herschman H, Alander C, Voznesensky O, Raisz L. | Talk | Eicosanoids and Other Bioactive Lipids in Cancer, Inflammation and Related Diseases | 1997 | La Jolla, CA |
Decreased parathyroid-stimulated resorption in cultured calvaria from neonatal mice with resistance to collagenase. Pilbeam C, Zhao W, Krane SM. | Poster | Gordon Research Conference, Matrix Metalloproteinases | 1997 | Andover, NH |
Regulation of prostaglandin synthesis in bone. | Talk | 10th International Conference on Prostaglandins and Related Compounds | 1996 | Vienna, Austria |
Osteoblastic differentiation reduces serum induced transcription of prostaglandin G/H synthase-2 in MC3T3-E1 cells. Pilbeam CC, Voznesensky OS, Alander CB, Raisz LG. | Poster | Bone, Abstracts from the Sixth Workshop on Cells and Cytokines in Bone and Cartilage | 1996 | |
The role of prostaglandins as local regulators of bone metabolism. | Talk | Research Trends in Osteoporosis, IBC UK Conference | 1995 | London, England |
Regulation of inducible prostaglandin G/H synthase promoter activity by transforming growth factor ß in osteoblastic MC3T3 E1 cells. Pilbeam C, Kawaguchi H, Voznesensky O, Alander C, Fletcher B, Herschman H, Raisz LG. | Talk | Xllth International Conference on Calcium Regulating Hormones | 1995 | Melbourne, Australia |
The regulation of prostaglandin synthesis in bone tissue. | Talk | Workshop on Prostaglandin and Bone: From Basic Research to Clinical Medicine | 1994 | Brussels, Belgium |
Regulation of inducible prostaglandin G/H synthase by interleukin 1, transforming growth factors alpha and ß, and prostaglandins in bone cells. Pilbeam CC, Kawaguchi H, Voznesensky O, Alander CB, Raisz LG. | Talk | 3rd International Conference on Eicosanoids and Other Bioactive Lipids in Cancer, Inflammation and | 1993 | Washington DC |
Separate regulation of the mRNA transcripts for the two prostaglandin endoperoxide synthases In MC3T3 E1 osteoblastic cells by serum and glucocorticoid. Pilbeam CC, Kawaguchi H, Voznesensky O, Alander CB, Raisz LG. | Talk | XXIIIrd European Symposium on Calcified Tissues | 1993 | Heidelberg, Germany |
Effects of calcium supple mentation on bone turnover in healthy older women Pannullo AM, Prestwood KM, Pilbeam CC, Raisz LG. | Talk | Annual meeting of the Gerontological Society of America | 1993 | |
aging bone | Talk | Yale New Haven Hospital Grand Rounds | 1993 | Yale New Haven Hospital |
Anabolic effect of progesterone on cultured fetal rat calvarial bone. Manzi DL, Pilbeam CC, Raisz LG. | Poster | Society for Gynecologic Investigations | 1993 | |
The effects of tamoxifen on bone turnover, lipids, and health perception in older women. Kenny AM, Prestwood KM, Pilbeam CC, Raisz L. | Poster | American Geriatrics Society | 1993 | |
osteoporosis and aging | Talk | Hartford Hospital Grand Rounds | 1992 | Hartford Hospital |
Quantitative reverse transcrip¬tase PCR: A new method to assess the expression of prostaglandin endoperoxide synthase in bone. Yavari R, Stover ML, Pilbeam C, Kawaguchi H, Raisz LG, Rowe D. | Poster | East Coast Connective Tissue Conference | 1992 | |
osteomalacia | Talk | John Dempsey Hospital Grand Rounds | 1991 | John Dempsey Hospital |
Inhibition of prostaglandin E2 production by 17ß estradiol in osteoblast like cells. Pilbeam C, Gustafson S, Alander C, Raisz LG. | Poster | The American Geriatrics Society meeting | 1991 | Chicago, IL |
In vitro inhibition of interleukin 1 stimulated prostaglandin E2 production by 17ß-estradiol. PiIbeam CC, Alander CB, Raisz LG. | Talk | Third International Workshop on Cells and Cytokines in Bone and Cartilage | 1990 | Davos, Switzerland |
osteoporosis | Talk | Winsted Memorial Hospital Grand Rounds | 1990 | Winsted Memorial Hospital |
vitamin D and aging | Talk | Mt. Sinai Hospital Grand Rounds | 1990 | Mt. Sinai Hospital |
osteoporosis | Talk | St. Francis Hospital Grand Rounds | 1990 | St. Francis Hospital |
Interaction of estrogen and PTH in osteoporosis. | Talk | NIH-sponsored Brookdale Foundation Summer Institute on Aging Research | 1989 | Bethesda, MD |
osteoporosis | Talk | William Beaumont Hospital Grand Rounds | 1989 | Detroit, MI |
In vitro inhibition of PTH stimulated resorption and prostaglandin production by 17ß estradiol. | Poster | Steenbock Symposium on Osteoporosis | 1989 | Madison, WI |
In vitro inhibition of PTH stimulated prostaglandin E2 production by 17ß estradiol. Pilbeam CC, Raisz LG. | Talk | Annual Meeting of the American Society for Bone and Mineral Research | 1988 | New Orleans, LA |
Vitamin D status in nursing home elders. Pilbeam CC, Webb AR, Holick MF. | Talk | Annual Meeting of the Gerontological Society of America | 1988 | San Francisco, CA |
(geriatrics, osteoporosis) | Talk | Waterbury Hospital Grand Rounds | 1988 | Waterbury Hospital |
Pilbeam CC, Webb AR, Hanifin N, Holick MF. Vitamin D status of residents in Boston nursing home. | Poster | The American Geriatrics Society meeting | 1988 | Boston, MA |
(osteoporosis) | Talk | St. Vincent's Medical Center Grand Rounds | 1987 | St. Vincent's Medical Center, Bridgeport |